Latest Drugs, Latest Approval in Miscellaneous bone resorption inhibitors

What are Miscellaneous bone resorption inhibitors?

Miscellaneous bone resorption inhibitors are drugs that inhibit mineralization or resorption of the bone. These agents work by different mechanisms to decrease bone resorption and prevent calcium loss from the bones. These bone resorption inhibitors are used to treat patients who have bone cancer or to treat patients who have excess calcium in the blood due to cancer.

Name Updated
Romosozumab (Romosozumab [ roe-moe-soz-ue-mab ]) 12-Aug-2023
Xgeva (Denosumab [ den-oh-sue-mab ]) 12-Jul-2023
Prolia (Denosumab (prolia) [ den-oh-sue-mab ]) 11-Jul-2023
Evenity (Romosozumab [ roe-moe-soz-ue-mab ]) 10-Jul-2023
Denosumab (Denosumab (prolia) [ den-oh-sue-mab ]) 10-Jul-2023